Human genome-editing research should proceed, say leading UK science bodies
Wednesday, September 2, 2015 - 04:30
in Psychology & Sociology
A group of leading UK research organisations has today issued an initial joint statement in support of the continued use of CRISPR-Cas9 and other genome-editing techniques in preclinical research. This includes the use of the technology for research purposes in human reproductive cells and early embryos, where this is fully justified, scientifically and ethically, and within the confines of the law.